Jaen Juan C.
President at RCUS; SVP, Drug Discovery & CSO at ChemoCentryx, Inc.
- Sold, on record
- $12.1M
- Dollars the filings state
- Form 4 sales
- 34
- Latest Jul 10, 2026
- Form 144 notices
- 9
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- RCUSArcus Biosciences, Inc.President
- ChemoCentryx, Inc.SVP, Drug Discovery & CSO
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- RCUS437,344 shares
- ChemoCentryx, Inc.145,000 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 144 notice RCUSNoticeDec 4, 2025 2025
Filed to sell 82,997 shares ($2.1M)
Jaen Juan C., Officer
10b5-1 plan3.1x usual sizeFiling
- 2 Form 4 sale RCUSUnusualDec 4, 2025 same day
Sold 82,997 shares at $24.71 ($2.1M)
Jaen Juan C., President
10b5-1 planSold 8% of holdings ($25.6M position)954,063 shares left3.1x usual sizeFollows a Form 144Filing
- 3 Form 144 notice RCUSNoticeDec 15, 2025 +11 days
Filed to sell 22,000 shares ($482k)
Jaen Juan C., Officer
10b5-1 plan0.6x usual sizeFiling
- 4 Form 4 sale RCUSRoutineDec 17, 2025 +2 days
Sold 21,208 shares at $22.01 ($467k)
Jaen Juan C., President
10b5-1 planSold 5.8% of holdings ($8.1M position)346,012 shares left0.6x usual sizeFollows a Form 144Filing
- 5 Form 144 notice RCUSNoticeJan 5, 2026 +19 days
Filed to sell 31,823 shares ($693k)
Jaen Juan C., Officer
10b5-1 plan0.8x usual sizeFiling
- 6 Form 4 sale RCUSRoutineJan 5, 2026 same day
Sold 31,823 shares at $21.41 ($681k)
Jaen Juan C., President
10b5-1 planSold 3.3% of holdings ($20.4M position)922,240 shares left0.8x usual sizeFollows a Form 144Filing
- 7 Form 4 sale RCUSRoutineJun 24, 2026 +170 days
Sold 31,431 shares at $27.92 ($878k)
Jaen Juan C., President
10b5-1 planSold 3.4% of holdings ($25.7M position)890,809 shares left0.8x usual sizeFiling
- 8 Form 4 sale RCUSRoutineJul 10, 2026 +16 days
Sold 68,569 shares at $29.63 ($2M)
Jaen Juan C., President
10b5-1 planSold 7.7% of holdings ($26.4M position)822,240 shares left2.2x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (43)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 10, 2026 | Jul 13, 2026 | RCUS | President | Form 4 sale | 68,569 | $2M | 7.7% | Routine | SEC |
| Jun 24, 2026 | Jun 24, 2026 | RCUS | President | Form 4 sale | 31,431 | $878k | 3.4% | Routine | SEC |
| Jan 5, 2026 | Jan 7, 2026 | RCUS | President | Form 4 sale | 31,823 | $681k | 3.3% | Routine | SEC |
| Jan 5, 2026 | Jan 5, 2026 | RCUS | Officer | Form 144 notice | 31,823 | $693k | Notice | SEC | |
| Dec 17, 2025 | Dec 18, 2025 | RCUS | President | Form 4 sale | 21,208 | $467k | 5.8% | Routine | SEC |
| Dec 15, 2025 | Dec 15, 2025 | RCUS | Officer | Form 144 notice | 22,000 | $482k | Notice | SEC | |
| Dec 4, 2025 | Dec 5, 2025 | RCUS | President | Form 4 sale | 82,997 | $2.1M | 8.0% | Unusual | SEC |
| Dec 4, 2025 | Dec 4, 2025 | RCUS | Officer | Form 144 notice | 82,997 | $2.1M | Notice | SEC | |
| Nov 18, 2025 | Nov 19, 2025 | RCUS | President | Form 4 sale | 50,000 | $1M | 4.6% | Routine | SEC |
| Nov 17, 2025 | Nov 17, 2025 | RCUS | Officer | Form 144 notice | 50,000 | $1000k | Notice | SEC | |
| Oct 30, 2025 | Nov 3, 2025 | RCUS | President | Form 4 sale | 4,314 | $88k | 0.4% | Routine | SEC |
| Oct 30, 2025 | Oct 30, 2025 | RCUS | Officer | Form 144 notice | 1,173 | $24k | Notice | SEC | |
| Oct 29, 2025 | Oct 30, 2025 | RCUS | President | Form 4 sale | 96,859 | $2M | 8.2% | Routine | SEC |
| Oct 28, 2025 | Oct 28, 2025 | RCUS | Officer | Form 144 notice | 100,000 | $2M | Notice | SEC | |
| Feb 27, 2024 | Feb 28, 2024 | RCUS | President | Form 4 sale | 27,032 | $543k | 2.2% | Unusual | SEC |
| Jan 2, 2024 | Jan 4, 2024 | RCUS | President | Form 4 sale | 6,975 | $140k | 0.6% | Routine | SEC |
| Jan 2, 2024 | Jan 2, 2024 | RCUS | Officer | Form 144 notice | 100,000 | $2M | Notice | SEC | |
| Dec 15, 2023 | Dec 15, 2023 | RCUS | Officer, Director | Form 144 notice | 8,500 | $149k | Notice | SEC | |
| Jun 15, 2023 | Jun 15, 2023 | RCUS | Officer, Director | Form 144 notice | 5,500 | $110k | Notice | SEC | |
| Dec 16, 2022 | Dec 16, 2022 | RCUS | President | Form 4 sale | 4,436 | $136k | 2.0% | Plan not stated | SEC |
| Jun 17, 2022 | Jun 21, 2022 | RCUS | President | Form 4 sale | 4,870 | $104k | 2.3% | Plan not stated | SEC |
| Dec 17, 2021 | Dec 20, 2021 | RCUS | President | Form 4 sale | 1,973 | $79k | 1.0% | Plan not stated | SEC |
| Jun 17, 2021 | Jun 21, 2021 | RCUS | President | Form 4 sale | 4,857 | $116k | 2.4% | Plan not stated | SEC |
| Mar 8, 2013 | Mar 11, 2013 | ChemoCentryx, Inc. | SVP, Drug Discovery & CSO | Form 4 sale | 2,795 | $39k | 8.5% | Plan not stated | SEC |
| Mar 6, 2013 | Mar 6, 2013 | ChemoCentryx, Inc. | SVP, Drug Discovery & CSO | Form 4 sale | 12,205 | $170k | 27.1% | Unusual | SEC |
| Feb 28, 2013 | Mar 1, 2013 | ChemoCentryx, Inc. | SVP, Drug Discovery & CSO | Form 4 sale | 12,599 | $161k | 21.9% | Unusual | SEC |
| Feb 26, 2013 | Feb 26, 2013 | ChemoCentryx, Inc. | SVP, Drug Discovery & CSO | Form 4 sale | 22,500 | $275k | 33.3% | Unusual | SEC |
| Feb 21, 2013 | Feb 21, 2013 | ChemoCentryx, Inc. | SVP, Drug Discovery & CSO | Form 4 sale | 22,201 | $264k | 33.0% | Unusual | SEC |
| Feb 15, 2013 | Feb 19, 2013 | ChemoCentryx, Inc. | SVP, Drug Discovery & CSO | Form 4 sale | 1,945 | $23k | 3.5% | Plan not stated | SEC |
| Feb 7, 2013 | Feb 8, 2013 | ChemoCentryx, Inc. | SVP, Drug Discovery & CSO | Form 4 sale | 1,555 | $18k | 2.9% | Plan not stated | SEC |
| Feb 4, 2013 | Feb 6, 2013 | ChemoCentryx, Inc. | SVP, Drug Discovery & CSO | Form 4 sale | 3,875 | $45k | 6.8% | Plan not stated | SEC |
| Feb 1, 2013 | Feb 1, 2013 | ChemoCentryx, Inc. | SVP, Drug Discovery & CSO | Form 4 sale | 10,005 | $116k | 15.9% | Plan not stated | SEC |
| Jan 29, 2013 | Jan 29, 2013 | ChemoCentryx, Inc. | SVP, Drug Discovery & CSO | Form 4 sale | 7,698 | $88k | 12.7% | Plan not stated | SEC |
| Jan 24, 2013 | Jan 24, 2013 | ChemoCentryx, Inc. | SVP, Drug Discovery & CSO | Form 4 sale | 1,300 | $15k | 2.4% | Plan not stated | SEC |
| Jan 12, 2013 | Jan 15, 2013 | ChemoCentryx, Inc. | SVP, Drug Discovery & CSO | Form 4 sale | 3,305 | $38k | 5.9% | Plan not stated | SEC |
| Jan 4, 2013 | Jan 4, 2013 | ChemoCentryx, Inc. | SVP, Drug Discovery & CSO | Form 4 sale | 6,017 | $68k | 10.2% | Plan not stated | SEC |
| Dec 18, 2012 | Dec 19, 2012 | ChemoCentryx, Inc. | SVP, Drug Discovery & CSO | Form 4 sale | 15,000 | $166k | 22.1% | Unusual | SEC |
| Nov 14, 2012 | Nov 16, 2012 | ChemoCentryx, Inc. | SVP, Drug Discovery & CSO | Form 4 sale | 2,000 | $26k | 3.6% | Plan not stated | SEC |
| Nov 6, 2012 | Nov 8, 2012 | ChemoCentryx, Inc. | SVP, Drug Discovery & CSO | Form 4 sale | 5,833 | $70k | 9.6% | Plan not stated | SEC |
| Oct 1, 2012 | Oct 1, 2012 | ChemoCentryx, Inc. | SVP, Drug Discovery & CSO | Form 4 sale | 2,400 | $29k | 3.8% | Plan not stated | SEC |
| Sep 25, 2012 | Sep 27, 2012 | ChemoCentryx, Inc. | SVP, Drug Discovery & CSO | Form 4 sale | 7,401 | $89k | 10.5% | Plan not stated | SEC |
| Sep 24, 2012 | Sep 24, 2012 | ChemoCentryx, Inc. | SVP, Drug Discovery & CSO | Form 4 sale | 3,566 | $43k | 4.8% | Plan not stated | SEC |
| Sep 17, 2012 | Sep 19, 2012 | ChemoCentryx, Inc. | SVP, Drug Discovery & CSO | Form 4 sale | 800 | $10k | 1.1% | Plan not stated | SEC |